FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileIDT Australia Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
IDT.AX
IDT Australia Limited Stock AnalysisComprehensive stock analysis for IDT Australia Limited (IDT.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisIDT.AX
IDT.AX
IDT Australia Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
IDT.AX
  1. Home
  2. Stocks
  3. IDT Australia Limited

IDT Australia Limited

🇦🇺IDT.AX•ASX

IDT Australia Limited

🇦🇺IDT.AX•ASX

Your view on IDT.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About IDT Australia Limited

Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Mark Simari
Headquarters
45 Wadhurst Drive, Boronia, VIC, AU
Industry
Drug Manufacturers - Specialty & Generic
Sector
Healthcare
CEO
Mark Simari
Headquarters
45 Wadhurst Drive, Boronia, VIC, AU
Description

IDT Australia Limited is an enterprise deeply involved in the entire lifecycle of pharmaceutical products, from initial research and development through to manufacturing and global distribution of both active pharmaceutical ingredients (APIs) and finished dosage forms.

The company furnishes comprehensive analytical support, including the establishment of testing methodologies, stability assessments utilizing specialized chambers, and quality control laboratory services for both chemical and microbiological applications.

Furthermore, its service offerings span project management, chemical processing, advanced analytical chemistry, pharmacy support, clinical trial packaging, and regulatory compliance assistance, alongside pharmaceutical development expertise across diverse dosage forms.

Notably, IDT Australia also provides medicinal cannabis products and a broad array of contract manufacturing solutions. Established in 1975, the firm is headquartered in Boronia, Australia.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for IDT Australia Limited. Starting points for IDT Australia Limited: EPS -AUD 0.0064, beta 0.94 — an Drug Manufacturers - Specialty & Generic name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for IDT Australia Limited. IDT Australia Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for IDT Australia Limited. Trailing twelve-month EPS for IDT Australia Limited stands at -AUD 0.0064. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for IDT Australia Limited. IDT Australia Limited has reported as a listed company since 1988. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold IDT.AX12 companies
More Drug Manufacturers - Specialty & Generic companies
TickerTypeCompanySectorExchangeMkt cap
SHEZFShenzhen Hepalink Pharmaceutical Group Co., Ltd.HealthcareOTC$690.3M
SHIEFShield Therapeutics plcHealthcareOTC$150.9M
SHPHShuttle Pharmaceuticals Holdings, Inc.HealthcareNASDAQ$18.2M
SHPHFSihuan Pharmaceutical Holdings Group Ltd.HealthcareOTC$1.6B
SIGASIGA Technologies, Inc.HealthcareNASDAQ$201.2M
SIGOSunset Island Group, Inc.HealthcareOTC$539
SKTOSK3 Group, Inc.HealthcareOTC$1,395
SKYISky Century Investment, Inc.HealthcareOTC$223,725
SLNXSolanbridge Group, Inc.HealthcareOTC$95,200
SMDPYSumitomo Pharma Co., Ltd.HealthcareOTC$6.1B
SNNVFSunniva Inc.HealthcareOTC$392
SNOASonoma Pharmaceuticals, Inc.HealthcareNASDAQ$4.2M
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for IDT Australia Limited. Coverage tracks IDT Australia Limited within Drug Manufacturers - Specialty & Generic (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of IDT Australia Limited.

IDT.AX AnalysisFair
Past
1
Growth
5
Health
3
Profit
1
Value
1

News

Latest Market News